List of redirects
Jump to navigation
Jump to search
Showing below up to 500 results in range #1 to #500.
- "Himalayan" P waves → Right atrial enlargement
- "Matrix extracellular phosphoglycoprotein" → Matrix extracellular phosphoglycoprotein
- "Nuclear skeleton" → Nucleoskeleton
- "Phosphorus oxoacids" → Phosphorus oxoacids
- "Port-wine" stain → Capillary malformation#Cutaneous and/or mucosal CM (“port-wine” stain)
- "Widget:Bookshelf" → Widget:Bookshelf
- "a" wave → A wave
- "cannon" A → Cannon a waves
- "cold state" → Cool extremities
- "cross-tolerance" → Cross-tolerance
- "fast-slow" AVNRT → Atypical AVNRT
- "locked in" syndrome → Locked-In syndrome
- "scotch-tape" test → Enterobiasis tape test
- "slow-fast" AVNRT → AVNRT Slow/Fast
- "slow-slow" AVNRT → AVNRT Slow/Slow
- "v" wave → V wave
- 'Himalayan' P waves → Right atrial enlargement
- 'lymphangioma circumscriptum' → Lymphatic malformation#Microcystic LM
- (+/-)-beta-Phenylisopropylamine → Adderall
- (-)-Thyroxine, 3,3',5,5'-Tetraiodo-L-thyronine → Levothyroxine
- (Eisenmenger's syndrome → Eisenmenger's syndrome
- (GERD) → Gastroesophageal reflux disease
- (Hb)A1c → Glycosylated hemoglobin
- (MPO) → Myeloperoxidase
- (carboxyethyl)arginine b-lactam-synthase → (carboxyethyl)arginine beta-lactam-synthase
- *K-C® → Kaolin and Pectin (patient information)
- *K-Pek® → Kaolin and Pectin (patient information)
- *Kapectolin® → Kaolin and Pectin (patient information)
- -phob- → Fear of fish
- 1,1,2,2,2-pentafluoroethane → Pentafluoroethane
- 1,2,4-triazole → 1,2,4-Triazole
- 1,2-dichloroethane → 1,2-Dichloroethane
- 1,25(OH)2D → Calcitriol
- 1,25-dihydroxy vitamin D → Calcitriol
- 1,3-BPG → 1,3-Bisphosphoglycerate
- 1,3-Dehydroadamantane → Propellane
- 1,3-bisphosphoglycerate → 1,3-Bisphosphoglycerate
- 1,3-butadiene → 1,3-Butadiene
- 1,3-cyclohexadiene → 1,3-Cyclohexadiene
- 1,3-dipolar cycloaddition → 1,3-Dipolar cycloaddition
- 1,3-β glucan synthase → 1,3-beta-glucan synthase
- 1,4,5-triphosphate → Inositol triphosphate
- 1,4-Naphthoquinone → Naphthoquinone
- 1,4-dioxane → 1,4-Dioxane
- 1,4-naphthoquinone → Naphthoquinone
- 1,4 Butanediol → 1,4-Butanediol
- 1,5-cyclooctadiene → 1,5-Cyclooctadiene
- 1,6-diaminohexane → Hexamethylenediamine
- 1-Butanol → N-Butanol
- 1-Pentanethiol → Stink bomb
- 1-Propanol → Propan-1-ol
- 1-deoxy-D-xylulose 5-phosphate → 1-Deoxy-D-xylulose 5-phosphate
- 1-methyl-4-benzylpiperazine → 1-Methyl-4-benzylpiperazine
- 10-propargyl-10-deazaaminopterin → Pralatrexate
- 10th cranial nerve disorder → Vagus nerve#Effects of vagus nerve lesions
- 11-b-hydroxylase deficiency → 11β-hydroxylase deficiency
- 11-beta HSD1 → 11β-hydroxysteroid dehydrogenase type 1
- 11-beta HSD2 → Corticosteroid 11-beta-dehydrogenase isozyme 2
- 11-beta hydroxysteroid dehydrogenase → 11Beta Hydroxysteroid dehydrogenase
- 11-cis retinal → Retinene
- 11-deoxycorticosterone → Deoxycorticosterone
- 11-hydroxy-THC → 11-Hydroxy-THC
- 11 Deoxycorticosterone → Deoxycorticosterone
- 11 b hydroxylase deficiency → 11β-hydroxylase deficiency
- 11 beta hydroxylase deficiency → 11β-hydroxylase deficiency
- 11 beta hydroxysteroid dehydrogenase type 2 deficiency → Apparent mineralocorticoid excess
- 11 hydroxylase deficiency → 11β-hydroxylase deficiency
- 11b-hydroxylase deficiency → 11β-hydroxylase deficiency
- 11b hydroxylase deficiency → 11β-hydroxylase deficiency
- 11q deletion → Jacobsen syndrome
- 11β-OH CAH → Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
- 11β-hydroxylase → Steroid 11-beta-hydroxylase
- 12-O-tetradecanoylphorbol-13-acetate → 12-O-Tetradecanoylphorbol-13-acetate
- 12-lead ECG → Echocardiography
- 12-lead ECGs → Electrocardiography
- 12-lead electrocardiograms → Electrocardiography
- 12 lead ECG → Electrocardiography
- 12th cranial nerve → Hypoglossal nerve
- 13-cis retinoic acid → Isotretinoin
- 14-3-3 epsilon → YWHAE
- 14α-demethylase → CYP51A1
- 16S rDNA → Ribosomal RNA
- 16s rRNA → Ribosomal RNA
- 17-Deoxycortisol → Corticosterone
- 17-Hydroxyprogesterone caproate → Hydroxyprogesterone caproate
- 17-N-allylamino-17-demethoxygeldanamycin → 17-N-Allylamino-17-demethoxygeldanamycin
- 17- beta-hydroxysteroid dehydrogenase deficiency → Male pseudohermaphroditism
- 17-alpha-hydroxylase deficiency → 17 alpha-hydroxylase deficiency
- 17-alpha-hydroxypregnenolone → 17-Hydroxypregnenolone
- 17-alpha-hydroxyprogesterone → 17-Hydroxyprogesterone
- 17-hydroxypregnenolone → 17-Hydroxypregnenolone
- 17-hydroxyprogesterone → 17-Hydroxyprogesterone
- 17BHSD3 → 17Beta Hydroxysteroid dehydrogenase
- 17OHP → 17-Hydroxyprogesterone
- 17 alpha hydroxylase deficiency → Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency
- 17 beta-hydroxysteroid dehydrogenase deficiency → 17-beta-hydroxysteroid dehydrogenase deficiency
- 17 beta hydroxysteroide dehydrogenase deficiency → Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency
- 17 hydroxylase deficiency → 17 alpha-hydroxylase deficiency
- 17 hydroxyprogesterone → 17-Hydroxyprogesterone
- 17α-Hydroxypregnenolone → 17-Hydroxypregnenolone
- 17α-hydroxylase → CYP17A1
- 18-hydroxylase → Aldosterone synthase
- 18-hydroxylation → Aldosterone synthase
- 18-methoxycoronaridine → 18-Methoxycoronaridine
- 18 Hydroxycorticosterone → 18-Hydroxycorticosterone
- 18 hydroxylase deficiency → 18-Hydroxylase deficiency
- 18p deletion syndrome → De Grouchy Syndrome
- 18q syndrome → De Grouchy Syndrome
- 1H-nuclear magnetic resonance spectroscopic imaging → Magnetic resonance imaging
- 1 E-21 J → Orders of magnitude (energy)#10-21
- 1 E-6 m → 1 micrometre
- 1 E-7 m → 100 nanometres
- 1 E-8 m → 10 nanometres
- 1 E-9 m → 1 nanometre
- 1p36 Deletion Syndrome → 1p36 deletion syndrome
- 1st degree AV block → First degree AV block
- 1st degree av block → First degree AV block
- 1st degree block → First degree AV block
- 1st degree heart block → First degree AV block
- 1st trimester → Pregnancy#First trimester
- 1α-hydroxylase → 25-Hydroxyvitamin D3 1-alpha-hydroxylase
- 2,2,4-trimethylpentane → 2,2,4-Trimethylpentane
- 2,3,7,8-tetrachlorodibenzo-p-dioxin → Polychlorinated dibenzodioxins
- 2,3-Butanedione → Diacetyl
- 2,3-Diethylpyrazine → Alkylpyrazine
- 2,3-Dimethylbutane → Dimethylbutane
- 2,3-Dimethylpyrazine → Alkylpyrazine
- 2,3-bisphosphoglycerate → 2,3-Bisphosphoglycerate
- 2,3-dimercapto-1-propanesulfonic acid → 2,3-Dimercapto-1-propanesulfonic acid
- 2,3-dimercaptosuccinic acid → Dimercaptosuccinic acid
- 2,4,5-T → 2,4,5-Trichlorophenoxyacetic acid
- 2,4,5-trichlorophenoxyacetic acid → 2,4,5-Trichlorophenoxyacetic acid
- 2,4-D → 2,4-Dichlorophenoxyacetic acid
- 2,4-dichlorophenoxyacetic acid → 2,4-Dichlorophenoxyacetic acid
- 2,4-dimethyl-6-tert-butylphenol → 2,4-Dimethyl-6-tert-butylphenol
- 2,4-dinitrophenylhydrazine → 2,4-Dinitrophenylhydrazine
- 2,4-dinitrophenylhydrazone → 2,4-Dinitrophenylhydrazine
- 2,4 Dienoyl CoA reductase → 2,4 Dienoyl-CoA reductase
- 2,5-Dimethylpyrazine → Alkylpyrazine
- 2,5-dimethoxy-4-(n)-propylthiophenethylamine → 2C-T-7
- 2,5-dimethoxy-4-bromoamphetamine → 2,5-Dimethoxy-4-bromoamphetamine
- 2,5-dimethoxy-4-ethylamphetamine → 2,5-Dimethoxy-4-ethylamphetamine
- 2,5-dimethoxy-4-iodoamphetamine → 2,5-Dimethoxy-4-iodoamphetamine
- 2,5-dimethoxy-4-methylamphetamine → 2,5-Dimethoxy-4-methylamphetamine
- 2,5-dimethoxy-4-nitroamphetamine → 2,5-Dimethoxy-4-nitroamphetamine
- 2,5-dimethoxyamphetamine → Dimethoxyamphetamine
- 2,6-Dimethylpyrazine → Alkylpyrazine
- 2,6-di-tert-butylphenol → 2,6-Di-tert-butylphenol
- 2-AG → 2-Arachidonoylglycerol
- 2-Acetyl-3-Ethylpyrazine → Alkylpyrazine
- 2-Butanone → Butanone
- 2-C-methyl-D-erythritol 4-phosphate → 2-C-methylerythritol 4-phosphate
- 2-Chloroethanol → 2-chloroethanol
- 2-D electrophoresis → Two-dimensional gel electrophoresis
- 2-Ethyl-3-Methylpyrazine → Alkylpyrazine
- 2-Hexanone → Silyl enol ether
- 2-Hydroxybutyrate → 2-Hydroxybutyric acid
- 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency → 2-Methylbutyryl-CoA dehydrogenase deficiency
- 2-PAM → Pralidoxime
- 2-Propanol → Isopropyl alcohol
- 2-acetylamino-fluorene → 2-Acetylaminofluorene
- 2-amino-5-phosphonovalerate → APV (NMDAR antagonist)
- 2-aminoisobutyric acid → 2-Aminoisobutyric acid
- 2-aminopurine → 2-Aminopurine
- 2-arachidonoyl glycerol → 2-Arachidonoylglycerol
- 2-arachidonylglycerol → 2-Arachidonoylglycerol
- 2-bromopropane → 2-Bromopropane
- 2-butene → Butene
- 2-hydroxyglutaricaciduria → 2-Hydroxyglutaricaciduria
- 2-iodoxybenzoic acid → 2-Iodoxybenzoic acid
- 2-methoxyestradiol → 2-Methoxyestradiol
- 2-oxoglutarate → Alpha-ketoglutaric acid
- 2-oxoglutarate dehydrogenase → Oxoglutarate dehydrogenase
- 2-phenoxyethanol → Phenoxyethanol
- 2-propylamine → Isopropylamine
- 20/20 → Visual acuity
- 2006 United States E. coli outbreak → 2006 North American E. coli outbreak
- 2019-nCoV → SARS-CoV-2
- 21-hydroxylase → 21-Hydroxylase
- 21-hydroxylase deficient CAH → 21-hydroxylase deficiency
- 21-hydroxylase deficient congenital adrenal hyperplasia → 21-hydroxylase deficiency
- 21 hydroxylase deficiency → 21-hydroxylase deficiency
- 21 hydroxylase deficient congenital adrenal hyperplasia → 21-hydroxylase deficiency
- 22q → 22q11.2 deletion syndrome
- 22q11.2DS → 22q11.2 deletion syndrome
- 22q11 deletion → 22q11.2 deletion syndrome
- 24-Dinitrotoluene → Toluene diisocyanate
- 24-hour ambulatory electrocardiogram → Holter monitor
- 24 h ambulatory ECG → Holter monitor
- 25-hydroxy vitamin D → Calcidiol
- 25-hydroxylase → CYP27A1
- 2CB → 2C-B
- 2CDA → Cladribine (patient information)
- 2CI → 2C-I
- 2D echocardiography → Two dimensional echocardiography
- 2IT-BAD monoclonal antibody 170 → Monoclonal antibodies
- 2b3a blocker → Glycoprotein IIb/IIIa inhibitors
- 2b3a inhibitor → Glycoprotein IIb/IIIa inhibitors
- 2nd degree av block → Second degree AV block
- 2nd degree block → Second degree AV block
- 2nd degree heart block → Second degree AV block
- 2nd metacarpal → Second metacarpal bone
- 2q37 microdeletion syndrome → Albright like syndrome
- 3',5'-cyclic-nucleotide phosphodiesterase → CGMP specific phosphodiesterase type 5
- 3'UTR → Three prime untranslated region
- 3' UTR → Three prime untranslated region
- 3' end → Directionality (molecular biology)
- 3' flanking region → Directionality (molecular biology)#3' end
- 3,4,5-trimethoxyamphetamine → Trimethoxyamphetamine
- 3,4-methylenedioxy-N-ethylamphetamine → MDEA
- 3,4-methylenedioxyamphetamine → 3,4-Methylenedioxyamphetamine
- 3,4-methylenedioxymetamphetamine → 3,4-Methylenedioxyamphetamine
- 3,4-methylenedioxymethamphetamine → Methylenedioxymethamphetamine
- 3-AP → 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
- 3-Methoxy-4,5-methylendioxyamphetamine → MMDA (psychedelic)
- 3-Methylcrotonylglycinuria type 1 → 3-Methylcrotonyl-CoA carboxylase deficiency
- 3-Methylglutaconic aciduria type II → Barth syndrome
- 3-Methylglutaconyl-CoA → 3-Methylglutaconyl CoA
- 3- Methylglutaconic aciduria type 3 → Methylglutaconyl-CoA hydratase
- 3-allylfentanyl → 3-Allylfentanyl
- 3-alpha hydroxysteroid dehydrogenase → Hydroxysteroid dehydrogenase
- 3-aminophenol → Aminophenol
- 3-aminopyridine-2-carboxaldehyde thiosemicarbazone → 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
- 3-center-4-electron bond → Three-center four-electron bond
- 3-dimensional conformal radiation therapy → Radiation therapy
- 3-dimensional radiation therapy → Radiation therapy
- 3-hydroxy 3-methyl glutaryl-coa lyase deficiency → 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
- 3-hydroxyacyl-coa dehydrogenase deficiency → 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
- 3-methoxy-4,5-methylendioxyamphetamine → MMDA (psychedelic)
- 3-methyl crotonyl-coa carboxylase deficiency → 3-Methylcrotonyl-CoA carboxylase deficiency
- 3-methyl glutaconic aciduria → 3-Methylglutaconic aciduria
- 3-methylcrotonyl-CoA carboxylase → Methylcrotonyl-CoA carboxylase
- 3-methylcrotonyl-CoA carboxylase deficiency → Methylcrotonyl-CoA carboxylase
- 3-methylfentanyl → 3-Methylfentanyl
- 3-methylglutaconic aciduria → 3-Methylglutaconic aciduria
- 3-methylglutaconyl-CoA hydratase → Methylglutaconyl-CoA hydratase
- 3-methylthiofentanyl → 3-Methylthiofentanyl
- 3-phosphoglycerate → Glycerate 3-phosphate
- 3-quinuclidinyl benzilate → 3-Quinuclidinyl benzilate
- 3CPO → Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema
- 3MCC deficiency → 3-Methylcrotonyl-CoA carboxylase deficiency
- 3T/2R → Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
- 3T/2R trial → Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
- 3 10 helix → 310 helix
- 3 beta hydroxysteroid dehydrogenase deficiency → Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency
- 3 day measles → Rubella
- 3 day rash → Roseola
- 3 methylglutaconyl coa hydratase deficiency → 3-Methylglutaconic aciduria
- 3a,7a-dihydroxy-5b-cholestanate-CoA ligase → 3alpha,7alpha-dihydroxy-5beta-cholestanate-CoA ligase
- 3rd degree block → Third degree AV block
- 3rd degree heart block → Third degree AV block
- 3rd heart sound → Heart sounds
- 3rd metacarpal → Third metacarpal bone
- 3rd trimester → Pregnance#Third trimester
- 3β-HSD → 3-beta-HSD
- 3β-HSD II deficient CAH → Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency
- 3β-Hydroxy-5-androsten-17-one → Dehydroepiandrosterone
- 3β-Hydroxyandrost-5-en-17-one → Dehydroepiandrosterone
- 3β-hydroxysteroid dehydrogenase → 3Beta Hydroxysteroid dehydrogenase
- 3βHSD CAH → Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency
- 4-Alpha-hydroxyphenylpyruvate hydroxylase deficiency → Hawkinsinuria
- 4-Bromo-2,5-dimethoxyphenethylamine → 2C-B
- 4-Chlordehydromethyltestosterone → 4-Chlorodehydromethyltestosterone
- 4-Dimethylaminoazobenzene → Methyl yellow
- 4-HO-DIPT → 4-HO-DiPT
- 4-HO-DMT → Psilocin
- 4-MA → PMA
- 4-NQO → 4-Nitroquinoline 1-oxide
- 4-Nonylphenol → Nonylphenol
- 4-alpha-glucanotransferase enzyme deficiency → Glycogen storage disease type III
- 4-aminophenol → Aminophenol
- 4-aminopyridine → 4-Aminopyridine
- 4-aminoquinolone → 4-Aminoquinoline
- 4-androstene-3,6,17-trione → 4-Androstene-3,6,17-trione
- 4-bromo-2,5-dimethoxy-amphetamine → 2,5-Dimethoxy-4-bromoamphetamine
- 4-chloro-2,5-dimethoxyamphetamine → 4-Chloro-2,5-dimethoxyamphetamine
- 4-demethoxydaunorubicin → Idarubicin (patient information)
- 4-hydoxybutyric aciduria → Succinic semialdehyde dehydrogenase deficiency
- 4-hydroxy-4-methylpentanoic acid → 4-Hydroxy-4-methylpentanoic acid
- 4-hydroxyphenylpyruvate → 4-Hydroxyphenylpyruvic acid
- 4-hydroxyphenylpyruvate dioxygenase → 4-Hydroxyphenylpyruvate dioxygenase
- 4-hydroxyphenylpyruvate hydroxylase deficiency → Hawkinsinuria
- 4-hydroxytamoxifen → Tamoxifen
- 4-methoxyamphetamine → PMA
- 4-methyl-2,5-dimethoxyamphetamine → 2,5-Dimethoxy-4-methylamphetamine
- 4-nitroquinoline 1-oxide → 4-Nitroquinoline 1-oxide
- 40 Winks → Diphenhydramine
- 4311/B Ciba → Methylphenidate
- 44-Methylenebis → Imidazolidinyl urea
- 45,X → Turner syndrome
- 454 life sciences → 454 Life Sciences
- 46,XX → Karyotype
- 46,XY → Karyotype
- 46 xx gonadal dysgenesis epibulbar dermoid → XX gonadal dysgenesis
- 47,XX,+21 → Down syndrome
- 47,XXX → Triple X syndrome
- 47,XXX aneuploidy → Triple X syndrome
- 47,XXX syndrome → Triple X syndrome
- 47,XXY → Klinefelter's syndrome
- 47,XY,+21 → Down syndrome
- 47,XYY → XYY syndrome
- 47,XYY Syndrome → XYY syndrome
- 47,XYY syndrome → XYY syndrome
- 47XXY → Klinefelter's syndrome
- 47 XXY syndrome → Klinefelter's syndrome
- 47 kDa Heat shock protein → Heat shock protein 47
- 47 xyy syndrome → XYY syndrome
- 48,XXYY syndrome → 48 XX,YY
- 48 xxxx syndrome → 48, XXXX
- 48 xxyy syndrome → 48 XX,YY
- 49,XXXXY syndrome → Klinefelter's syndrome
- 49 xxxxx syndrome → 49, XXXXX
- 49 xxxxy syndrome → 49 XXXXY syndrome
- 4D → Deutsche Diabetes Dialysis Study
- 4D Ultrasound → 3D ultrasound
- 4E → Efficacy And Safety Of Eplerenone, Enalapril, And Eplerenone/Enalapril Combination Therapy In Patients With Left Ventricular Hypertrophy
- 4S → Scandinavian Simvastatin Survival Study
- 4T score → Heparin-induced thrombocytopenia diagnostic criteria
- 4p- syndrome → Wolf-Hirschhorn syndrome
- 4p syndrome → Wolf-Hirschhorn syndrome
- 4th heart sound → Heart sounds
- 5' → Directionality (molecular biology)#5' end
- 5'-nucleotidase → Liver function tests
- 5'UTR → Five prime untranslated region
- 5' UTR → Five prime untranslated region
- 5' end → Directionality (molecular biology)
- 5,10-methylenetetrahydrofolate → 5,10-Methylenetetrahydrofolate
- 5,5-Dwufenylohydantoina → Phenytoin
- 5,5-diphenylhydantoin → Phenytoin
- 5,6,7,8-tetrahydrobiopterin → Tetrahydrobiopterin
- 5,6,7,8 tetrahydrobiopterin → Tetrahydrobiopterin
- 5-Alpha-reductase deficiency → 5-alpha-reductase deficiency
- 5-Azacytidine → Azacytidine
- 5-FU → Fluorouracil
- 5-Fluorocytosine → Flucytosine
- 5-Fluorouracil → Fluorouracil
- 5-HIAA → 5-Hydroxyindoleacetic acid
- 5-HPETE → Arachidonic acid 5-hydroperoxide
- 5-HT → Serotonin
- 5-HT1 → 5-HT1 receptor
- 5-HT1A → 5-HT1A receptor
- 5-HT1E → 5-HT1E receptor
- 5-HT1F → 5-HT1F receptor
- 5-HT1 agonist → 5-HT1 receptor
- 5-HT2 → 5-HT2 receptor
- 5-HT3 receptor antagonist → 5-HT3 antagonist
- 5-HT4 → 5-HT4 receptor
- 5-HT5A → 5-HT5A receptor
- 5-HT6 → 5-HT6 receptor
- 5-HT7 → 5-HT7 receptor
- 5-HTP → 5-Hydroxytryptophan
- 5-HT receptor 2C → 5-HT2C receptor
- 5-MeO-DIPT → 5-Methoxy-diisopropyltryptamine
- 5-MeO-MIPT → 5-MeO-MiPT
- 5-Meo-DMT → 5-MeO-DMT
- 5-alpha-reductase → 5-alpha reductase
- 5-alpha reductase deficiency → 5-alpha-reductase deficiency
- 5-azacytidine → 5-Azacytidine
- 5-bromo-2-deoxy-uridine → Bromodeoxyuridine
- 5-carboxytryptamine → 5-HT receptor
- 5-fluorouracil → Fluorouracil
- 5-hydroxyindoleacetic acid → 5-Hydroxyindoleacetic acid
- 5-hydroxytryptamine → Serotonin
- 5-lipoxygenase → Arachidonate 5-lipoxygenase
- 5-lipoxygenase activating protein → 5-Lipoxygenase activating protein
- 5-methoxy-N,N-diisopropyltryptamine → 5-Methoxy-diisopropyltryptamine
- 5-methoxytryptamine → 5-Methoxytryptamine
- 5-methylcytosine → 5-Methylcytosine
- 5-methyltetrahydrofolate → 5-Methyltetrahydrofolate
- 5-methyltetrahydrofolate-homocysteine methyltransferase → 5-Methyltetrahydrofolate-homocysteine methyltransferase
- 5-methylthioribose-1-phosphate isomerase → S-methyl-5-thioribose-1-phosphate isomerase
- 5-phosphorybosylamine → Phosphoribosylamine
- 506U78 → Nelarabine
- 510(k) → Federal Food, Drug, and Cosmetic Act
- 5HT → Serotonin
- 5HT1A → 5-HT1A receptor
- 5HT1B → 5-HT1 receptor#5-HT1B
- 5HT1D → 5-HT1D receptor
- 5HT4 receptor → 5-HT receptor
- 5Q- syndrome → 5q- syndrome
- 5 alpha reductase 2 deficiency → 5-alpha-reductase deficiency
- 5 alpha reductase deficiency → 5-alpha-reductase deficiency
- 5 hydroxytryptamine → Serotonin
- 5alpha-reductase → 5-alpha reductase
- 5p- Syndrome → Cri du chat
- 5p Deletion Syndrome → Cri du chat
- 5p minus → Cri du chat syndrome
- 5p syndrome → Cri du chat syndrome
- 5th digit → Little finger
- 5th metacarpal → Fifth metacarpal bone
- 6-hydroxydopamine → 6-Hydroxydopamine
- 6-hydroxymethylacylfulvene → Irofulven
- 6-mercaptopurine → Mercaptopurine
- 6-phosphogluconate → 6-Phosphogluconate
- 6-phosphogluconate dehydrogenase → Phosphogluconate dehydrogenase
- 6-phosphoglucono-δ-lactone → 6-Phosphogluconolactone
- 6-pyruvoyl-tetrahydropterin synthase deficiency → 6-Pyruvoyltetrahydropterin synthase deficiency
- 6-pyruvoyltetrahydropterin synthase deficiency → 6-Pyruvoyltetrahydropterin synthase deficiency
- 6C trial → Cooperative Colorectal Cancer Combination Chemotherapy Clinical
- 6th disease → Roseola
- 7+3 → 7+3 regimen
- 7-dehydrocholesterol → 7-Dehydrocholesterol
- 7-dehydrocholesterol reductase → 7-Dehydrocholesterol reductase
- 7-dehydrocholesterol reductase deficiency → Smith-Lemli-Opitz syndrome
- 7-dehydrositosterol → 7-Dehydrositosterol
- 7HP → Allopurinol
- 7TM Receptor → G protein-coupled receptor
- 8-Hydroxyquinolone → 8-Hydroxyquinoline
- 8-Mop → Methoxsalen
- 8-chlorotheophylline → 8-Chlorotheophylline
- 80 Lead ECG → 80 Lead EKG
- 80 lead ECGs → 80 Lead EKG
- 80 lead EKG → 80 Lead EKG
- 9-cis retinoic acid → Retinoid
- 911 → Emergency medical services
- 990 → WBR0991
- 9p syndrome → Tetrasomy 9p
- A,a-phosphotrehalase → Alpha,alpha-phosphotrehalase
- A-COMET-I → Azimilide—Cardioversion Maintenance Trial–I
- A-COMET-II → Azimilide—Cardioversion Maintenance Trial–II
- A-F → Vascular Protection In High-Risk Non–St-Elevation Acute Coronary Syndromes: The Angioplasty Balloon-Associated Coronary Debris And The Ez Filterwire
- A-HeFT → African-American Heart Failure Trial
- A-Hydrocort → Cortisol
- A-L-fucosidase → Alpha-L-fucosidase
- A-Methapred → Methylprednisolone
- A-Pak Laboratories Paediatric Analgesic Paracetamol → Paracetamol detailed information
- A-Spas S/L → Hyoscyamine (patient information)
- A-T → Ataxia telangiectasia
- A-V dissociation → Atrioventricular dissociation
- A-alphalipoprotein Neuropathy → Tangier disease
- A-fib → Atrial fibrillation
- A-glucosidase → Maltase
- A-kinase anchoring protein → AKAP
- A-mannosidase → Alpha-Mannosidase
- A-methylacyl-CoA racemase → Alpha-methylacyl-CoA racemase
- A-pinene-oxide decyclase → Alpha-pinene-oxide decyclase
- A-ribazole phosphatase → Alpha-ribazole phosphatase
- A-scan → A-scan ultrasound biometry
- A. profunda brachii → Profunda brachii
- A.i.d.s. → AIDS
- A00-A09 → ICD-10 Chapter I: Certain infectious and parasitic diseases#(A00-A09) [[Intestinal
- A00-B99 → ICD 10 Chapter I
- A1AD → Alpha 1-antitrypsin deficiency
- A1AT deficiency → Alpha 1-antitrypsin deficiency
- A1BG gene transcription → A1BG gene transcriptions
- A1C → Glycosylated hemoglobin
- A2 → Heart sounds
- A2A receptor → Adenosine A2A receptor
- A2 phospholipase → Phospholipase
- A2 receptor → Alpha-2 adrenergic receptor
- A33 monoclonal antibody → Monoclonal antibodies
- A4 Study → Catheter Ablation Versus Antiarrhythmic Drugs For Atrial Fibrillation
- AAA → Abdominal aortic aneurysm
- AAA+ → AAA proteins
- AAASPS → African American Antiplatelet Stroke Prevention Study
- AACHEN → Angiotensin II Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation
- AADD → Adult attention-deficit disorder
- AAFP → American Academy of Family Physicians
- AAMI → Association for the Advancement of Medical Instrumentation
- AAS → Aarskog-Scott syndrome
- AASK → African American Study Of Kidney Disease And Hypertension
- AAT → Alpha 1-antitrypsin deficiency
- AATD → Alpha 1-antitrypsin deficiency
- AAT deficiency → Alpha 1-antitrypsin deficiency
- AA Amyloidosis → Secondary amyloidosis
- AA amyloidosis → Secondary amyloidosis
- AA cell → AA battery
- AA type amyloidosis → AA amyloidosis
- ABACAS → Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study
- ABC-Transporter Genes → ATP-binding cassette transporter
- ABC-transporter → ATP-binding cassette transporter
- ABCD → Alternans Before Cardioverter Defibrillator
- ABC Plus Senior → Multivitamin
- ABC study → Association Of Black Cardiologists Study Of Hypertension
- ABC to Z → Multivitamin
- ABC transporter → ATP-binding cassette transporter
- ABC transporters → ATP-binding cassette transporter
- ABG → Arterial blood gas
- ABI → Peripheral arterial disease screening
- ABI-007 → Paclitaxel
- ABL → Abl gene
- ABL1 → Abl gene
- ABL1 gene → Abl gene
- ABL2 gene → ABL2
- ABLC → Amphotericin B lipid complex
- ABO → ABO blood group system
- ABOARD → Immediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome
- ABO hemolytic disease of the newborn → Hemolytic disease of the newborn (ABO)
- ABPA → Aspergillosis
- ABSOLUTE NEUTROPHIL COUNT → Absolute neutrophil count
- ABSORB: 6-month and 2-year results → A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
- ABVE-PC regimen → DBVE-PC regimen
- ACA → Acrodermatitis chronica atrophicans
- ACADEMIC → Azithromycin In Coronary Artery Disease: Elimination Of Myocardial Infection With Chlamydia
- ACAS → Asymptomatic Carotid Atherosclerosis Study
- ACC → American College of Cardiology
- ACC/AHA guidelines for evaluation of unoperated patients with atrial septal defects → ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
- ACC/AHA guidelines for reproduction in patients with atrial septal defect → Atrial septal defect pregnancy#2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[4
- ACC/AHA guidelines inferior vena cava filter → Pulmonary embolism guidelines inferior vena cava filter
- ACC/AHA guidelines surgical embolectomy → Pulmonary embolism ACC/AHA guidelines surgical embolectomy